证券代码：920015 证券简称：锦华新材 公告编号：2025-120 浙江锦华新材料股份有限公司 关于签署募集资金三方监管协议的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、募集资金情况概述 浙江锦华新材料股份有限公司（以下简称"公司"、"锦华新材"）向不特 定合格投资者公开发行股票并在北京证券交易所上市申请已于 2025 年 7 月 4 日 经北京证券交易所上市委员会审核通过，并收到中国证券监督管理委员会于 2025 年 8 月 12 日出具的《关于同意浙江锦华新材料股份有限公司向不特定合格 投资者公开发行股票注册的批复》（证监许可[2025]1710 号）。 公司本次公开发行股票 32,666,667 股（超额配售选择权行使前），每股发行 价格为人民币 18.15 元，募集资金总额为人民币 592,900,006.05 元（超额配售选 择权行使前），扣除不含税的发行费用人民币 43,754,025.53 元（超额配售选择权 行使前），实际募集资金净额为人民币 549,145,980.5 ...

Summary of Key Points Core Viewpoint The trading activity on the Beijing Stock Exchange (BSE) showed a significant decrease in transaction volume and value on September 26, with a total trading volume of 799 million shares and a transaction value of 19.456 billion yuan, down by 1.469 billion yuan compared to the previous trading day. Despite this decline, 80 stocks closed higher, indicating some resilience in the market. Trading Activity - The total trading volume on the BSE was 799 million shares, with a transaction value of 19.456 billion yuan, reflecting a decrease of 1.469 billion yuan from the previous day [1]. - Among the traded stocks, 80 closed higher, accounting for 28.99% of the total tradable stocks [1]. - The stocks with the highest closing gains included Jinhua New Materials (up 29.98%), Wuxin Tunnel Equipment (up 7.98%), and Silane Technology (up 7.54%) [1][2]. - Conversely, 193 stocks closed lower, with Jinhao Medical leading the declines at 11.00% [1]. Stock Performance - Jinhua New Materials had the highest trading volume at 1.158 billion yuan and a turnover rate of 74.80% [1]. - Other notable stocks in terms of trading volume included Wuxin Tunnel Equipment (572.73 million yuan) and Naconoer (504.29 million yuan) [1]. - The trading activity showed that 15 stocks had a turnover rate exceeding 10%, with three stocks exceeding 20% [1]. Market Dynamics - The overall market sentiment was mixed, with a notable number of stocks experiencing significant price fluctuations [1][2]. - The trading data indicates a potential shift in investor sentiment, as evidenced by the number of stocks that experienced both gains and losses [1][2]. Conclusion The BSE experienced a decline in trading activity on September 26, yet a portion of stocks demonstrated resilience with notable gains. The market dynamics suggest a complex environment where investor sentiment may be shifting, warranting close observation of future trading patterns and stock performances [1][2].

Core Points - JinHua New Materials (920015) saw a significant increase of 133.00% on its first trading day, with a turnover rate of 91.23% and a transaction volume of 1.132 billion yuan [2] - The stock's first-day margin trading amounted to 17.8716 million yuan, accounting for 1.58% of the total trading volume, with a latest margin balance of 15.3305 million yuan, representing 1.17% of the circulating market value [2] Company Overview - The company primarily engages in the research, development, production, and sales of ketoxime series fine chemicals [3]

Core Insights - The Beijing Stock Exchange (BSE) is experiencing a rapid expansion phase, with a notable increase in IPO activities and subscription rates for new stocks [1][2] Group 1: Company Developments - Hangdongguang Communication Technology Co., Ltd. has met the requirements for issuance, listing, and information disclosure, and is set to proceed with its IPO [1] - The company plans to raise nearly 500 million yuan for various projects, including the expansion of its manufacturing base in Guilin and a new optical research center [2] - Hangdongguang's revenue and net profit have shown significant growth, particularly in overseas sales, which increased from 75% to approximately 90% of its main business revenue from 2022 to 2024 [2][3] Group 2: Market Performance - Zhejiang Jinhua New Materials Co., Ltd. debuted on the BSE with a remarkable first-day increase of 133%, closing at 42.29 yuan after opening at 39 yuan [4] - The company raised a total of 593 million yuan through its IPO, with a total market capitalization of 5.526 billion yuan [4] - Subscription for Jinhua New Materials reached a record high of 468 billion shares, indicating strong market demand and investor enthusiasm [5] Group 3: Industry Trends - The BSE has maintained a high frequency of new stock issuances, with a notable uptick in the pace of IPOs and subscriptions in recent weeks [1] - The average first-day return for new stocks listed on the BSE this year has exceeded 349.98%, showcasing a robust market environment for new listings [5] - The overall market sentiment remains positive, with significant liquidity and investor interest in new stock offerings [5]

Summary of Key Points Core Viewpoint - On September 25, the total trading volume of individual stocks on the Beijing Stock Exchange reached 881 million shares, with a total transaction value of 20.925 billion yuan, reflecting a decrease of 0.895 billion yuan compared to the previous trading day. Among the traded stocks, 40 stocks closed higher, while 235 stocks closed lower [1]. Trading Performance - The stock that saw the highest increase was Jinhua New Materials (920015), which surged by 133.00% with a closing price of 42.29 yuan and a turnover rate of 91.23%, resulting in a transaction value of 1.132 billion yuan [2]. - Other notable gainers included Jinhao Medical, which rose by 19.04%, and Haidar, which increased by 8.30% [1][2]. - Conversely, the largest declines were observed in Dadi Electric, which fell by 9.67%, Anhui Phoenix by 8.31%, and Xin'an Clean by 7.89% [1]. Market Activity - A total of 56 stocks on the Beijing Stock Exchange had transaction values exceeding 100 million yuan, with Jinhua New Materials, Better Ray, and Chuangyuan Xinke leading the list [2]. - The trading activity indicated that 18 stocks had a turnover rate exceeding 10%, with three stocks exceeding 20% [2]. Detailed Trading Data - The trading details for the top stocks included: - Jinhua New Materials: Closing price 42.29 yuan, increase 133.00%, turnover rate 91.23%, transaction value 1.132 billion yuan [2]. - Better Ray: Closing price 32.60 yuan, decrease 1.57%, turnover rate 1.39%, transaction value 509.66 million yuan [2]. - Chuangyuan Xinke: Closing price 29.91 yuan, decrease 4.32%, turnover rate 15.93%, transaction value 502.36 million yuan [2].

Core Points - N Jinhua (920015) was listed on the Beijing Stock Exchange, opening with a significant increase of 114.88% and closing with a total gain of 133.00% [2] - The company specializes in the research, production, and sales of ketoxime series fine chemicals [2] Financial Performance - The net profits for the company are projected to be 79.59 million yuan in 2022, 173 million yuan in 2023, and 211 million yuan in 2024 [3] - The public offering consisted of 32.67 million shares at an issuance price of 18.15 yuan, resulting in a price-to-earnings ratio of 11.52 [3] Issuance Details - The online issuance volume was initially 26.13 million shares, which was increased to 31.03 million shares due to an oversubscription mechanism [3] - The effective subscription amount for the online issuance reached 46,897,366.69 million shares, with a subscription multiple of 1511.19 times and a distribution ratio of 0.07% [3] Market Performance - The trading volume for N Jinhua on its first day was 28.31 million shares, with a total transaction value of 1.132 billion yuan and a turnover rate of 91.23% [2] - A comparison of recent IPOs shows that N Jinhua's first-day closing price of 42.29 yuan represents a 133.00% increase from its issuance price [3][4]

Core Points - Zhejiang Jinhua New Materials Co., Ltd. (Jinhua New Materials) was listed on the Beijing Stock Exchange, opening at 39.00 CNY and closing at 42.29 CNY, marking a 133.00% increase with a trading volume of 1.132 billion CNY and a turnover rate of 91.23% [1] Company Overview - Jinhua New Materials specializes in the research, production, and sales of ketoxime series fine chemicals, including silane crosslinking agents, hydroxylamine salts, methoxyamine hydrochloride, and acetaldehyde oxime [1] - The company is controlled by Juhua Group Co., Ltd., which holds 82.49% of the shares, while the Zhejiang Provincial State-owned Assets Supervision and Administration Commission indirectly holds 90.00% of Juhua Group [1] Financial Highlights - The total amount raised from the issuance before the exercise of the over-allotment option was 592.90 million CNY, with a net amount of 549.15 million CNY after deducting issuance costs [3] - The company plans to use the raised funds for a 60kt/a high-end coupling agent project, a 500 tons/year JH-2 pilot project, and the construction of a ketoxime industrial chain smart factory [3][4] Performance Metrics - Jinhua New Materials reported revenues of 993.97 million CNY, 1.114 billion CNY, and 1.239 billion CNY for the years 2022, 2023, and 2024 respectively, with net profits of 79.59 million CNY, 172.51 million CNY, and 210.94 million CNY during the same period [5][6] - For the first half of 2025, the company reported revenues of 570.62 million CNY, a decrease of 11.68% year-on-year, and net profits of 113.55 million CNY, down 11.48% year-on-year [7] Future Projections - The company forecasts a revenue of 1.063 billion CNY and a net profit of 199.39 million CNY for the year 2025, representing a decline of 14.25% and 5.47% respectively compared to the previous year [7]

Group 1 - The core viewpoint of the news is the successful listing of N Jinhua on the Beijing Stock Exchange, with significant initial trading performance [1][2] - The stock opened with a surge of 114.88% and reached a peak increase of 147.99% by midday, with a trading volume of 24.0942 million shares and a turnover of 950 million yuan [1] - The company specializes in the research, production, and sales of ketoxime series fine chemicals [1] Group 2 - The company's net profits for 2022, 2023, and 2024 are projected to be 79.5922 million yuan, 173 million yuan, and 211 million yuan respectively [2] - The public offering consisted of 32.6667 million shares at an issuance price of 18.15 yuan, with an issuance price-to-earnings ratio of 11.52 times [2] - The effective subscription amount for the online offering was 4.68973669 billion shares, resulting in a subscription multiple of 1511.19 times and an allocation ratio of 0.07% [2]

Core Points - N Jinhua (920015) was listed on the Beijing Stock Exchange today, opening at 39.00 yuan, an increase of 114.88% from its issue price [2] - The company specializes in the research, production, and sales of ketoxime series fine chemicals [2] - The listing application was accepted on June 21, 2024, taking a total of 461 days from acceptance to listing [2] Financial Summary - The company issued 32.67 million shares at an issue price of 18.15 yuan, with an earnings per share (EPS) ratio of 11.52 times [2] - The online issuance volume was 26.13 million shares, with an oversubscription of 49 million shares, increasing the online issuance to 31.03 million shares [2] - The effective subscription amount for this issuance was 4,689,736.69 million shares, resulting in a subscription multiple of 1511.19 times and an allocation ratio of 0.07% [2] Profit Forecast - The company's net profits for 2022, 2023, and 2024 are projected to be 79.59 million yuan, 173 million yuan, and 211 million yuan respectively [3]

Core Viewpoint - The recent listings of Jianfa Zhixin, United Power, and Jinhua New Materials on the stock exchanges highlight the growth and investment opportunities in the medical device and new energy sectors in China [1][2]. Group 1: Jianfa Zhixin - Jianfa Zhixin is a national high-value medical device distributor, primarily engaged in direct sales and distribution, providing centralized operation services for medical consumables to hospitals [1]. - The company has a market capitalization of 2.97 billion yuan, with an issuance price of 7.05 yuan per share and a P/E ratio of 13.29, significantly lower than the industry average of 25.73 [2]. - In 2024, Jianfa Zhixin's revenue is projected to be divided into three segments: direct sales (11.03 billion yuan, 61.69%), distribution (6.74 billion yuan, 37.68%), and services (112 million yuan, 0.63%) [4]. - The company plans to invest 1.4 billion yuan in information system upgrades, 1.04 billion yuan in centralized operation services, and 2.4 billion yuan to supplement working capital [3]. Group 2: United Power - United Power, spun off from the industrial automation giant Inovance Technology, specializes in new energy vehicle power systems, including electric drive and power supply systems [6][7]. - The company is a leader in the new energy vehicle power system sector, providing solutions to over 40 vehicle manufacturers and participating in the entire lifecycle of vehicle design and production [7]. - United Power's accounts receivable have increased significantly, with values of 1.85 billion yuan, 3.61 billion yuan, and 5.68 billion yuan from 2022 to 2024, representing 20.37%, 29.38%, and 31.45% of total assets respectively [8]. Group 3: Jinhua New Materials - Jinhua New Materials focuses on the research, production, and sales of ketoxime series fine chemicals, being a leader in the domestic silane crosslinking agent market with market shares of 27.85%, 31.60%, and 38.16% from 2022 to 2024 [9]. - The company's products are essential for various industries, including construction, energy, electronics, and new energy vehicles [9]. - Jinhua New Materials has received multiple national honors and has participated in the formulation of several industry standards [9].